Introduction
Most conversations about regulatory affairs pay focus on a single number: base salary. That's understandable—it's the figure that's easiest to compare and the one candidates fixate on when evaluating an offer—but it's also an incomplete picture of what a regulatory affairs job actually pays. Total compensation in this field is typically built from several distinct components layered on top of base salary, and understanding how those pieces work, and how they vary by company type and career stage, matters more for evaluating an offer than knowing the base number alone. This isn't a rundown of specific salary figures, which vary too much by region, company, and year to state usefully here; it's a guide to the structure itself, so you know what questions to ask and what to look for when comparing offers.
Base Salary Is Only the Starting Point
Base salary is the fixed, guaranteed portion of pay, and it's the number most job postings reference when they include a range at all. It's the right starting point for comparing offers, but treating it as the whole picture leads candidates to undervalue offers with a lower base and stronger variable compensation, or overvalue offers with a high base and little else attached. Base salary also tends to be the slowest-moving part of compensation—raises are typically incremental and tied to annual review cycles—while the other components below can shift more significantly year to year based on company and individual performance.
Annual Bonus Structures: How They're Usually Built
Most regulatory affairs roles above entry level, and many at entry level too, include an annual performance bonus, usually structured as a target percentage of base salary rather than a fixed dollar amount. That target percentage typically scales with seniority, meaning a Director-level bonus target is meaningfully higher, proportionally, than an Associate-level one. Actual payout against that target usually depends on some combination of individual performance and overall company or business unit results, which means the bonus is rarely guaranteed at the full target amount in a given year, even for strong individual performers, if company-level results fall short. When evaluating an offer, it's worth asking not just what the target bonus percentage is, but what the actual historical payout has looked like against that target, since the gap between target and typical payout can be substantial at some companies and minimal at others.
Equity and Long-Term Incentives: More Common Than You'd Think
Equity compensation isn't limited to tech companies. Public biotech and pharmaceutical companies commonly grant equity, often in the form of restricted stock units or stock options, to regulatory affairs employees well below the executive level, particularly at mid-size and smaller companies where equity is used deliberately to attract talent that a larger, more established competitor might otherwise out-hire on base salary alone. Private companies, including venture-backed biotechs, may also offer equity in the form of stock options, though the value of that equity is inherently more speculative and dependent on a future liquidity event that may or may not happen on the timeline or at the value hoped for. Candidates evaluating equity as part of an offer should understand the vesting schedule, whether the equity is time-based or performance-based, and for private company equity, should treat the stated value with real skepticism until there's a clear path to liquidity.
Sign-On Bonuses and When They Show Up
Sign-on bonuses tend to appear in specific situations rather than as a routine part of every offer: when a candidate is walking away from an unvested bonus or equity at their current employer, when a role has been difficult to fill and a company wants to close the gap between offer and acceptance, or when a candidate is relocating and incurring real costs to take the job. They're typically a one-time payment, sometimes with a clawback clause if the employee leaves within a defined period, which is worth reading carefully before accepting. A sign-on bonus is a reasonable thing to ask for when a candidate is genuinely leaving compensation on the table elsewhere, but it's rarely something companies offer proactively without being asked.
Benefits That Function as Compensation
Health insurance, retirement plan matching, paid time off policies, and other benefits don't show up in a base salary number, but they carry real financial value and vary more between employers than candidates often assume. A retirement plan with a generous employer match, for instance, functions as meaningful additional compensation over time, even though it never appears in a stated salary figure. Some companies also offer benefits more specific to the regulatory and life sciences field, like professional development budgets that cover certification costs, conference attendance, or continuing education, which matter more to regulatory professionals specifically than they would in many other fields given how much the profession values ongoing credentialing and staying current with evolving guidance. Flexible or unlimited paid time off policies deserve a closer look than the label suggests, too, since how a policy actually functions in practice—whether time off is genuinely encouraged and taken, or nominally offered but rarely used because of workload culture—matters more than the policy name itself, and that's a fair thing to ask about directly, including to a would-be future teammate rather than only the hiring manager.
Remote Work and Geographic Pay Adjustments
As remote and hybrid regulatory affairs roles have become more common, geographic pay adjustment has become a more visible part of compensation conversations. Some companies pay a single national rate regardless of location, while others adjust pay based on the cost of labor in a candidate's location, which can mean the same role pays differently depending on where an employee lives. Neither approach is universal, and it's a reasonable, increasingly common question to ask directly during an offer conversation: how does location factor into the compensation being offered, and would that change if the employee later relocates.
How Compensation Structure Changes by Company Type and Stage
The relative weight of these components shifts significantly depending on the kind of company doing the hiring. Large, established pharmaceutical and device companies tend to offer higher, more predictable base salaries with more modest bonus and equity components, reflecting their scale and lower risk profile. Smaller or earlier-stage biotech companies often offer a lower base salary paired with a larger equity component and sometimes a higher bonus target, reflecting both the higher risk of the venture and a genuine attempt to compete for talent against larger, better-funded competitors. Consulting and CRO environments tend to structure compensation differently still, sometimes with billability-linked bonus structures or overtime-eligible pay depending on level and jurisdiction. None of these structures is inherently better; they represent different risk and reward tradeoffs that suit different candidates' financial situations and risk tolerance differently.
How to Evaluate a Total Compensation Package, Not Just a Number
When comparing offers, it helps to build out each component separately rather than trying to compress everything into a single comparable number, since equity value in particular resists easy comparison across companies with different risk profiles. A useful approach is to ask, for each offer, what's guaranteed (base salary and any guaranteed portion of a sign-on), what's likely but not guaranteed (a bonus at typical historical payout levels), and what's speculative (equity value at private companies, or bonus payout in a genuinely uncertain year for a public company). Comparing offers along those three tiers, rather than adding everything into one headline number, produces a much more honest picture of what each offer is actually worth, and it puts a candidate in a stronger position to negotiate the specific components that matter most to their own situation.
Questions Worth Asking Before You Negotiate
Before responding to an offer, it's worth asking a short, specific set of questions rather than negotiating against an incomplete picture. What has actual bonus payout looked like against target over the last few years, not just the target percentage itself? Is equity time-based, performance-based, or some mix of both, and what's the full vesting schedule? Does a sign-on bonus carry a clawback if you leave within a certain period, and how long is that period? How, if at all, does the company adjust pay for remote employees in different locations, and would that change with a future move? None of these questions are confrontational to ask, and a company that structures compensation thoughtfully should be able to answer them clearly. A vague or evasive answer to a direct question like this is itself useful information about how the offer, and the company more broadly, actually works.
Conclusion
Regulatory affairs compensation is genuinely more than a single base salary figure, and understanding how bonus targets, equity, sign-on bonuses, benefits, and geographic adjustments fit together is what separates a surface-level offer comparison from a real one. None of these components is inherently more valuable than another in the abstract; what matters is understanding how each piece works at a specific company and weighing that against your own financial priorities and risk tolerance. Asking direct, specific questions about each component during an offer conversation isn't aggressive or inappropriate—it's exactly the kind of informed evaluation that leads to a decision you won't second-guess six months into the job.